ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 52-Week Low at

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.60 and last traded at $14.68, with a volume of 628880 shares traded. The stock had previously closed at $15.09. Analysts Set New Price Targets Several brokerages have […]

Related Keywords

Canada , United States , America , James Kihara , Markc Schneyer , Jpmorgan Chase Co , Shell Asset Management Co , Covestor Ltd , Headlands Technologies , Citigroup , Quest Partners , Pharmaceuticals Daily , Nasdaq , Pharmaceuticals Inc , Pharmaceuticals Price Performance , Royal Bank , Acadia Pharmaceuticals Inc , Get Free Report , Management Fondsmaeglerselskab , Shell Asset Management , Asset Management ,